Control Bionics Limited (ASX: CBL)
Sector: Health Care
Market cap: A$28M (as of 2 Nov 2026)
Technology company that designs, manufactures and sells augmentative and alternative communication technology that allows users to operate and communicate via computer using their thoughts and neural signals
Data as of 2 Nov 2026.
Recent capital raises
Substantial holders — latest moves
| Date | Holder | Move | Holding | Source |
|---|---|---|---|---|
| 12 Aug 2026 | Phoenix Development Fund Limited | Increase | 16.19% → 16.45% | Filing ↗ |
| 12 Aug 2026 | Nightingale Partners Pty Ltd | Increase | 18.33% → 19.16% | Filing ↗ |
| 3 July 2026 | Phoenix Development Fund Limited | Decrease | 17.4% → 16.19% | Filing ↗ |
| 10 June 2026 | Nightingale Partners Pty Ltd | Decrease | 19.45% → 18.33% | Filing ↗ |
| 9 June 2026 | Phoenix Development Fund Limited | Decrease | 19.86% → 17.4% | Filing ↗ |
Director trades — on-market
Cash and runway
Ask about CBL in Claude or ChatGPT
Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:
- Has CBL raised money in the last year, and at what discount?
- What was CBL's latest cash position and runway?
Loading CBL…